Kleiner Perkins related stories
All articles and analysis
- Modern Health takes in $9 mln Series A
San Francisco-based Modern Health, a mental well-being benefits platform for employers, has raised $9 million in Series A funding. Kleiner Perkins, Jared Leto, Y Combinator and Afore led the round.
- Modern Health takes in $9 mln Series A
San Francisco-based Modern Health, a mental well-being benefits platform for employers, has raised $9 million in Series A funding. Kleiner Perkins, Jared Leto, Y Combinator and Afore led the round.
- Personal coaching platform Future snags $8.5 mln Series A
Future, a personal coaching platform, has raised $8.5 million in Series A funding. Kleiner Perkins led the round. In addition to the funding, Mamoon Hamid, a partner at Kleiner Perkins, will join Future's board of directors.
- Personal coaching platform Future snags $8.5 mln Series A
Future, a personal coaching platform, has raised $8.5 million in Series A funding. Kleiner Perkins led the round. In addition to the funding, Mamoon Hamid, a partner at Kleiner Perkins, will join Future's board of directors.


- Riverwood Capital leads $123 mln for Nextdoor
San Francisco-based Nextdoor Inc, a social network for the neighborhood, has secured $123 million in funding. Riverwood Capital led the round with participation from other investors that included Benchmark, Tiger Global Management and Kleiner Perkins. In conjunction with the funding, Chris Varelas, co-founder and managing partner of Riverwood Capital, will join Nextdoor's board of directors.

- VC-backed TransMedics debuts IPO
Andover, Massachusetts-based TransMedics, a medical technology company, has raised over $91 million for its IPO after pricing its nearly 5.7 million shares at $16 per share. The stock began trading May 2, 2019 on the NASDAQ under the ticker symbol "TMDX." Morgan Stanley and J.P. Morgan are the lead underwriters. The company's pre-IPO backers include Flagship Pioneering and Kleiner Perkins.
- Mary Meeker’s Bond Capital attracts $1.25 bln for maiden fund: reports
Mary Meeker’s Bond Capital has confirmed a target of $1.25 billion for its maiden venture-capital fund, and, according to media reports, attracted commitments for the capital.